NeuroXess

About NeuroXess

NeuroXess is a life science company founded in 2021 by Tiger Tao and Phoenix Peng, specializing in brain-computer interface (BCI) technology. The company is focused on developing and commercializing BCI systems to assist patients with paralysis, epilepsy, and other neurological disorders. Co-founder Tiger Tao is an expert in BCI, AI, and micro-sensing, while co-founder Phoenix Peng is a serial entrepreneur, previously the founder and CEO of the SaaS company Keruyun.

NeuroXess has developed a fully implantable, wireless BCI system that uses a flexible polyimide and metal mesh that sits on the surface of the brain without penetrating the tissue. This design aims to minimize tissue damage and reduce infection risks associated with external hardware. The system includes a battery module implanted subcutaneously in the chest, enabling wireless power and data transmission. The company has achieved significant milestones, including China's first human implantation of a fully implanted BCI with an integrated battery in late 2025. Clinical trials have demonstrated the technology's ability to allow paralyzed patients to control computer cursors, play video games, and operate smart devices using their thoughts. One trial participant achieved a brain-control decoding rate of 5.2 bits per second.

The company's technology has also shown success in decoding complex language, achieving high accuracy in real-time decoding of Chinese syllables. This breakthrough has potential applications for restoring communication in patients with speech impairments. NeuroXess operates on a dual-track model where Tao leads research on cutting-edge technologies, and Peng heads the commercialization efforts. Its clients include hospitals, universities, and research centers. Having raised over $13.9 million through multiple funding rounds from investors like Shanda Capital, Sequoia Capital, and Zhongping Capital, NeuroXess plans to accelerate the commercialization of its products. The company is part of China's strategic push to become a leader in the BCI industry, supported by government initiatives and funding.